Depression and Anxiety Trial, Recruiting NCT07028216 Sponsor: Georgetown University Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07028216
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with one of the following current conditions: social anxiety disorder, generalized anxiety disorder, panic disorder, agoraphobia, or major depressive disorder.
  • You score low on a self-compassion questionnaire (the trial team will measure this).
  • You are willing to attend all study visits and take part in the treatment as assigned.
  • You are able to understand and agree to the study procedures by giving informed consent.

Who may not be able to join:

  • You have a psychiatric condition other than anxiety or depression, such as a psychotic disorder, OCD, an eating disorder, bipolar disorder, a developmental or organic mental disorder, a substance use disorder in the past 6 months, or current PTSD.
  • You have a serious physical health condition that may require surgery or a hospital stay.
  • You have a history of a head injury that caused you to lose consciousness for a prolonged time, or you currently have problems with memory or thinking.
  • You are unable to understand the study procedures or the consent process, or you have significant personality-related difficulties that may make it hard to take part (confirm with trial site).
  • The trial team believes you are unlikely to follow the study procedures — for example, if you have planned travel that would cause you to miss visits.
  • You are currently taking certain psychiatric medications, such as barbiturates or antipsychotics. Some sleep medications and antidepressants may be allowed if you have been on a stable dose for at least 8 weeks before the study starts and plan to stay on the same dose throughout.
  • You have started a new type of talking therapy within the past month, or you are currently receiving therapy specifically aimed at treating anxiety, such as Cognitive Behavioral Therapy (CBT).
  • You have completed a Mindful Self-Compassion (MSC) course or a similar meditation program within the past year.
  • You are currently experiencing significant thoughts of suicide or have had suicidal behavior within the past year.
  • You have a medical condition (for example, epilepsy) that the study doctor or nurse thinks could be made worse by the study treatment.
  • You are unable to give your own consent to take part.
  • You are currently pregnant.
  • You are currently a prisoner.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Elizabeth Hoge, MD, Georgetown University

Phone: 202-687-7283

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Georgetown University
Registry
ClinicalTrials.gov
Start date
1 June 2025
Est. completion
17 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Self-Critical Rumination Scale (SCRS); Hospital Anxiety and Disease Scale (HADS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov